IL HB0156 | 2019-2020 | 101st General Assembly

Status

Spectrum: Partisan Bill (Democrat 27-1)
Status: Engrossed on April 12 2019 - 50% progression
Action: 2019-05-17 - Rule 3-9(a) / Re-referred to Assignments
Pending: Senate Assignments Committee
Text: Latest bill text (Engrossed) [HTML]

Summary

Creates the Prescription Drug Pricing Transparency Act. Requires health insurers to disclose certain rate and spending information concerning prescription drugs and certain prescription drug pricing information to the Department of Public Health. Requires the Department and health insurers to create annual lists of prescription drugs on which the State spends significant health care dollars and for which costs have increased at a certain rate over time. Requires the Department and health insurers to provide their lists to the Attorney General. Requires prescription drug manufacturers to notify the Attorney General if they are introducing a new prescription drug at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program. Amends the Illinois Insurance Code. Requires a group or individual policy of accident and health insurance that provides coverage for prescription drugs to apply the same cost-sharing requirements to interchangeable biological products as apply to generic drugs under the policy. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are met). Requires that when a pharmacist receives a prescription from a Medicaid recipient, the pharmacist shall select the preferred drug or biological product from the State's preferred drug list. Makes other changes. Makes conforming changes in the Freedom of Information Act. Effective immediately.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

BIOLOGICAL PRODUCTS-DRUG PRICE

Sponsors


Roll Calls

2019-04-12 - House - Third Reading in House (Y: 65 N: 41 NV: 2 Abs: 1) [PASS]
2019-04-12 - House - Motion in House (Y: 69 N: 39 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2019-05-17SenateRule 3-9(a) / Re-referred to Assignments
2019-05-10SenateRule 2-10 Committee Deadline Established As May 17, 2019
2019-05-09SenatePostponed - Insurance
2019-05-03SenateSponsor Removed Sen. Sue Rezin
2019-05-01SenatePostponed - Insurance
2019-04-30SenateAdded as Alternate Co-Sponsor Sen. Sue Rezin
2019-04-24SenateAdded as Alternate Chief Co-Sponsor Sen. Pat McGuire
2019-04-24SenateAssigned to Insurance
2019-04-22SenateAlternate Chief Sponsor Changed to Sen. John G. Mulroe
2019-04-19SenateAdded as Alternate Co-Sponsor Sen. David Koehler
2019-04-12SenateAdded as Alternate Chief Co-Sponsor Sen. John G. Mulroe
2019-04-12SenateAdded as Alternate Chief Co-Sponsor Sen. Jacqueline Y. Collins
2019-04-12SenateReferred to Assignments
2019-04-12SenateFirst Reading
2019-04-12SenateChief Senate Sponsor Sen. Antonio Muñoz
2019-04-12SenatePlaced on Calendar Order of First Reading
2019-04-12SenateArrive in Senate
2019-04-12HouseAdded Co-Sponsor Rep. Camille Y. Lilly
2019-04-12HouseAdded Chief Co-Sponsor Rep. Will Guzzardi
2019-04-12HouseThird Reading - Short Debate - Passed 065-041-000
2019-04-12HousePlaced on Calendar Order of 3rd Reading - Short Debate
2019-04-12HouseFiscal Note Request is Inapplicable
2019-04-12HouseMotion Prevailed 069-039-000
2019-04-12HouseHouse Committee Amendment No. 1 Note / Motion Filed - Note Act Does Not Apply Rep. Mary E. Flowers
2019-04-11HouseAdded Co-Sponsor Rep. Aaron M. Ortiz
2019-04-11HouseAdded Co-Sponsor Rep. Joyce Mason
2019-04-11HouseAdded Co-Sponsor Rep. Lamont J. Robinson, Jr.
2019-04-11HouseAdded Co-Sponsor Rep. Jennifer Gong-Gershowitz
2019-04-11HouseAdded Co-Sponsor Rep. Anne Stava-Murray
2019-04-11HouseAdded Co-Sponsor Rep. Anna Moeller
2019-04-11HouseAdded Co-Sponsor Rep. Robert Martwick
2019-04-11HouseAdded Co-Sponsor Rep. Ann M. Williams
2019-04-11HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
2019-04-11HouseAdded Co-Sponsor Rep. Robyn Gabel
2019-04-11HouseAdded Co-Sponsor Rep. Gregory Harris
2019-04-11HouseAdded Co-Sponsor Rep. Sara Feigenholtz
2019-04-11HouseAdded Co-Sponsor Rep. Celina Villanueva
2019-04-11HouseAdded Co-Sponsor Rep. Delia C. Ramirez
2019-04-11HouseAdded Co-Sponsor Rep. Carol Ammons
2019-04-11HouseAdded Co-Sponsor Rep. Theresa Mah
2019-04-11HouseHouse Committee Amendment No. 1 State Mandates Fiscal Note Filed as Amended
2019-04-10HouseHeld on Calendar Order of Second Reading - Short Debate
2019-04-10HouseSecond Reading - Short Debate
2019-04-04HouseRemove Chief Co-Sponsor Rep. Michael Halpin
2019-04-04HouseAdded Chief Co-Sponsor Rep. Sonya M. Harper
2019-04-01HouseHouse Committee Amendment No. 1 Fiscal Note Requested as Amended by Rep. Tom Demmer
2019-03-29HousePlaced on Calendar 2nd Reading - Short Debate
2019-03-27HouseDo Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 011-006-000
2019-03-27HouseHouse Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote
2019-03-26HouseHouse Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
2019-03-21HouseHouse Committee Amendment No. 1 Referred to Rules Committee
2019-03-21HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Mary E. Flowers
2019-03-15HouseAdded Co-Sponsor Rep. Debbie Meyers-Martin
2019-03-08HouseAdded Co-Sponsor Rep. Dan Caulkins
2019-02-14HouseAdded Chief Co-Sponsor Rep. Michael J. Zalewski
2019-02-07HouseAdded Chief Co-Sponsor Rep. LaToya Greenwood
2019-01-29HouseAssigned to Prescription Drug Affordability & Accessibility Committee
2019-01-09HouseReferred to Rules Committee
2019-01-09HouseFirst Reading
2018-12-10HousePrefiled with Clerk by Rep. Mary E. Flowers

Code Citations

ChapterArticleSectionCitation TypeStatute Text
2155356z.33New CodeSee Bill Text
2258516dNew CodeSee Bill Text
2258519.5Amended CodeCitation Text
2258519.7New CodeSee Bill Text
2258525Amended CodeCitation Text
2258541Amended CodeCitation Text
51407.5Amended CodeCitation Text

Illinois State Sources


Bill Comments

feedback